Searched for
SUN PHARMA DOMESTIC BUSINESS PERFORMANCE
Weekly Horoscope for ♌ LEO (July 4 - July 10, 2026): Where Will Leo Find Its Biggest Breakthrough This Week?Leo Weekly Horoscope (4th July 2026 to 10th July 2026): Leo, this week brings renewed confidence and the opportunity to step into a positio...- Adani Enterprises QIP gets nearly 4x bids, successfully raises Rs 15,000 croreAdani Enterprises successfully raised ₹15,000 crore through a qualified institutional placement, attracting significant interest from both ...
- Inspira seals Rs 1,800-crore private credit for Burger King buy in IndiaInspira Global, backed by Ajanta Pharma promoters, is securing ₹1,800 crore in private credit to acquire a controlling stake in India's Bur...
- Dalal Street also smokes peace pipe, ends in green for 4th week in rowIndian stock markets concluded their fourth consecutive week of gains, buoyed by declining crude oil prices and improved geopolitical senti...
- Inspira seals ₹1,800-cr private credit for Burger King buy in IndiaInspira Global, backed by Ajanta Pharma promoters, is securing ₹1,800 crore in private credit to acquire a controlling stake in Burger King...
- Sun Pharma secures relief in 'Pantocid' trademark disputeDelhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'P...
- Astral's demerger plan triggers sharp selloff, brokerages trim target pricesAstral's stock dipped 11% after announcing a demerger of its chemicals business. Investors are concerned about the valuation and growth pro...
- Jailer 2 release date confirmed: Rajinikanth's highly anticipated sequel to hit theaters this year; Check official date and teaserGet ready for 'Jailer 2'! The much-awaited sequel starring Rajinikanth will hit theatres worldwide on October 15. Directed by Nelson Dilipk...
- Nifty eyes 25,000 as July rally builds; banking, realty and auto lead the charge: Rohit SrivastavaMarket strategist Rohit Srivastava anticipates a strong summer for Indian equities, with the Nifty poised for gains. He highlights banking,...
- Toyota Kirloskar Motor's June sales rise 7% on stronger domestic demandToyota Kirloskar Motor witnessed a robust 7% surge in total sales for June, reaching 31,016 units. This growth was fueled by an 8% rise in ...
- Waterways Leisure shares slip on debut, list at 16% discount to IPO priceAhead of the listing, the IPO is commanding a grey market premium (GMP) of -Rs 51, implying a 6.31% discount to the upper price band of Rs ...
- Sensex rises over 200 points, Nifty above 24,000; Maruti Suzuki shares jump 3%Indian stock markets rebounded on Tuesday, with both Sensex and Nifty climbing approximately 0.4% after a dip in the previous session. The ...
- Market wrap: Sensex falls 372 points, Nifty closes below 23,950; Kotak Mahindra Bank drops 3%Indian markets ended lower as Sensex and Nifty snapped a two-session winning streak, pressured by geopolitical tensions in the Middle East ...
- 2 top stock recommendations from Vinay RajaniIndian equity markets are experiencing a cautious phase, consolidating within a defined range as fresh buying momentum remains elusive. Tec...
- Quote of the Day by Sun Tzu: "Place your army on death ground, and it will survive; plunge it into desperate straits, and it will..." — Ultimate life lessons on winning the war: The Art of War reveals why your greatest victories begin when retreat is impossibleQuote of the Day by Sun Tzu explores one of history's most enduring lessons on courage, commitment, and human psychology. In Chapter 11 of ...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- Nominal GDP growth could fuel largecap recovery; pharma, auto ancillaries remain preferred bets: Shreyash DevalkarIndian stock markets are defying foreign investor caution, driven by resilient June-quarter earnings. Companies are navigating geopolitical...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Reliance, financials and defence top investment picks as market leadership broadens: Rahul ShahReliance Industries is poised for a turnaround, with strong earnings, a Jio Platforms IPO, and AI/energy investments promising significant ...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
Load More
